Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
Background: HER2-overexpression promotes malignancy by modulating signalling molecules, which include PTPs/DSPs (protein tyrosine and dual-specificity phosphatases). Our aim was to identify PTPs/DSPs displaying HER2-associated expression alterations.
Main Authors: | Maria Antonietta Lucci, Rosaria Orlandi, Tiziana Triulzi, Elda Tagliabue, Andrea Balsari, Emma Villa-Moruzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.3233/CLO-2010-0520 |
Similar Items
-
Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK
by: Emma Villa-Moruzzi
Published: (2011-01-01) -
Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host
by: Martina Di Modica, et al.
Published: (2017-01-01) -
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
by: Tiziana Triulzi, et al.
Published: (2019-01-01) -
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
by: Tiziana Triulzi, et al.
Published: (2013-01-01) -
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
by: Ilona Rybinska, et al.
Published: (2020-02-01)